These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25484119)

  • 21. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity.
    Brown M; Zhang Y; Dermine S; de Wynter EA; Hart C; Kitchener H; Stern PL; Skinner MA; Stacey SN
    Gene Ther; 2000 Oct; 7(19):1680-9. PubMed ID: 11083477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
    Wendtner CM; Nolte A; Mangold E; Buhmann R; Maass G; Chiorini JA; Winnacker EL; Emmerich B; Kotin RM; Hallek M
    Gene Ther; 1997 Jul; 4(7):726-35. PubMed ID: 9282174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
    Pang XH; Chen MS; Jia WH; Zhou XX
    Ai Zheng; 2008 Dec; 27(12):1233-8. PubMed ID: 19079985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24.
    Chiriva-Internati M; Liu Y; Weidanz JA; Grizzi F; You H; Zhou W; Bumm K; Barlogie B; Mehta JL; Hermonat PL
    Blood; 2003 Nov; 102(9):3100-7. PubMed ID: 12855576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
    Ge C; Xing Y; Wang Q; Xiao W; Lu Y; Hu X; Gao Z; Xu M; Ma Y; Cao R; Liu J
    Int Immunopharmacol; 2011 Dec; 11(12):2200-7. PubMed ID: 22015603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of two different antigen-loading methods on the activity of dendritic cell vaccine for colorectal carcinoma cell inhibition in vitro].
    Huang H; Wang H; Wu ZQ; You CX; Luo RC; Yong L; Hermonat PL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):492-5. PubMed ID: 17545041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.
    Liu Y; Butterfield LH; Fu X; Song Z; Zhang X; Lu C; Ding G; Wu M
    Int J Oncol; 2011 Jul; 39(1):245-53. PubMed ID: 21491085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells.
    Seo MJ; Kim GR; Son YM; Yang DC; Chu H; Min TS; Jung ID; Park YM; Han SH; Yun CH
    Mol Immunol; 2011 Sep; 48(15-16):1744-52. PubMed ID: 21632112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector.
    Batchu RB; Gruzdyn OV; Moreno-Bost AM; Szmania S; Jayandharan G; Srivastava A; Kolli BK; Weaver DW; van Rhee F; Gruber SA
    Vaccine; 2014 Feb; 32(8):938-43. PubMed ID: 24406390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.
    Xie LH; Sin FW; Cheng SC; Cheung YK; Chan KT; Xie Y; Xie Y
    Cancer Immunol Immunother; 2008 Jul; 57(7):1029-38. PubMed ID: 18157497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity.
    Liu Y; Zhou W; You C; Zheng H; You H; Liu H; Zhang D; Luo R; Kay HH; Hermonat PL
    Vaccine; 2006 Mar; 24(10):1615-24. PubMed ID: 16289277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY; Wang L; Lu MD; Li BJ; Huang JF
    Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells.
    Yu Y; Pilgrim P; Yan J; Zhou W; Jenkins M; Gagliano N; Bumm K; Cannon M; Milzani A; Dalle-Donne I; Kast WM; Cobos E; Chiriva-Internati M
    J Transl Med; 2008 Oct; 6():56. PubMed ID: 18834548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells.
    Liang W; Wang XF
    Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.